| Georgianna Potter, RPH | |
|
180 Niblick Rd, Paso Robles, CA 93446-4842 | |
| (805) 238-2626 | |
| (805) 238-2049 |
| Full Name | Georgianna Potter |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 180 Niblick Rd, Paso Robles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316356975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 50442 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Georgianna Potter, RPH 180 Niblick Rd, Paso Robles, CA 93446-4842 Ph: (805) 238-2626 | Georgianna Potter, RPH 180 Niblick Rd, Paso Robles, CA 93446-4842 Ph: (805) 238-2626 |
News Archive
Many young children who get a severe skin rash develop asthma months or years later. Doctors call the progression from eczema, or atopic dermatitis, to breathing problems the atopic march. In the May 2009 issue of PLoS Biology, scientists at Washington University School of Medicine in St. Louis report another step taken towards understanding the process of atopic march.
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.
Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.
The Independent Allocation Vaccine Group (IAVG) was established by the WHO in January 2021 and is composed of 12 members who serve in their personal, independent capacities to review and assess Vaccine Allocation Decision (VAD) proposals generated by the COVAX Facility Joint Allocation Taskforce (JAT) on the volumes of vaccines that should be allocated to each participant under COVAX within a given time frame.
› Verified 4 days ago
Mrs. Maria C De Nysschen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Abigail Victoria Joy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
Sarah Elizabeth Stafford, BPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Ms. Minakshi Gurbhele, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
David Bircher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Kellie Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Stuart Wensil, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Niblick Rd, Paso Robles, CA 93446 Phone: 805-237-1803 Fax: 805-237-8768 |